Results 151 to 160 of about 501,137 (299)
A nebulized nanoassembly alleviates radiation‐induced lung injury by reprogramming macrophages through coordinated ROS scavenging, NAD+ replenishment, and PPAR‐γ activation. Redox balance, mitochondrial homeostasis, and immune regulation are restored, revealing a microenvironment‐centered strategy for localized radioprotection.
Mingquan Gao +11 more
wiley +1 more source
A Comprehensive Meta-Analysis and Review of Intraoperative Radiotherapy in Colorectal Cancer: Examining Radiation Dosage, Long-Term Prognosis, and Treatment-Related Complications. [PDF]
Guo C +7 more
europepmc +1 more source
A double‐layered shell‐core microneedle patch is developed to co‐deliver FOLFIRINOX, surufatinib, and anti‐PD‐1 for localized chemo‐immunotherapy of PDAC. This strategy achieves sustained tumor suppression, reduces metastasis, and reprograms the TME by enhancing CD8+ T‐cell infiltration and inhibiting Tregs and M2 macrophages infiltration, while ...
Tingting Kong +13 more
wiley +1 more source
Novel pharmacological perspectives in radiotherapy
Radiotherapy is an integral part of oncotherapy, usually used in combination with surgical therapy and/or chemotherapy in order to enhance the overall effect.
Bánffy, Balázs
core
Comparative dosimetric analysis of flattening-filter and flattening-filter-free photon beams in radiotherapy based on TRS-398 calibration protocol. [PDF]
Sakinah S +3 more
europepmc +1 more source
Estimation of Biological Dosage Factors in Clinical Radiotherapy [PDF]
openaire +2 more sources
Orally administered, pH‐responsive Co‐SAN exerts dual functions: in the alkaline intestinal milieu, it scavenges reactive oxygen species (ROS) and suppresses the PI3K/AKT pathway and NETs formation, thus providing radioprotection; whereas in the acidic tumor microenvironment, it generates ROS and alleviates hypoxia, thereby enhancing radiosensitization.
Shengqi Yin +13 more
wiley +1 more source
Obstacles and Trials in Treating Primary Brain Tumors. [PDF]
Popescu SO +3 more
europepmc +1 more source
In TP53mut GBM cells, reduced P53 function is associated with increased TET1 expression. Genetic or pharmacological inhibition of TET1 correlates with genome fragility, including DNA damage, cellular senescence, telomere shortening, and reactive oxygen species accumulation, which may contribute to increased efficacy of antitumor therapy.
Zhuonan Pu +12 more
wiley +1 more source
Viability of dental implants in patients treated for oral squamous carcinoma: A retrospective study. [PDF]
Sukumaran A, Jain PV, Arun P, Ahmed A.
europepmc +1 more source

